SSI Mantra Creates Global Footprint: Nepal’s First Surgical Robot Set to Transform Healthcare Sector
SS Innovations, the developer of India’s first indigenous surgical robotic
AIMS Faridabad is hosting a week-long celebration to honor its
Uttar Pradesh govt caps rate of COVID-19 test by private labs at ₹2,500
The Uttar Pradesh government on Thursday capped the rate of a coronavirus test by private laboratories at ₹2,500. An official statement said that private
Hospitals delaying pay of health staff on COVID-19 duty could be penalised: Centre
The Centre on Thursday warned states that hospitals and institutions not releasing salaries of healthcare workers engaged in COVID-19 duty timely could get penalised
‘EDISON[X] BY GE HEALTHCARE GRADUATES FIVE STARTUPS AT DEMO DAY
GE Healthcare today announced the graduation of its first batch of startups who were part of Cohort-1 of ‘Edison[X] - Startups powered by GE
Harsh Vardhan launches mobile laboratory for coronavirus testing
The mobile lab, also called I-Lab or Infectious Diseases Diagnostics Lab, can run 50 RT-PCR and about 200 ELISA tests in a day. NEW DELHI:
A Tale of Transplant in Tough Times: 45-years-old undergoes successful Liver Transplant, Lockdown delays return to Sudan Or The Life and Hard Times of a 45-years-old Sudanese Patient who underwent a successful Liver transplant in Delhi
Manipal Hospitals New Delhi gives a new lease of life to a Sudanese patient, COVID-19 and lockdown delays return of patient Osama Ali to
Transasia Bio-Medicals partners with AMTZ to launch India’s first, state-of-the-art mobile lab for RT-PCR and ELISA testing for COVID-19 in the heartland of India
Conceived and developed at lightning speed and manufactured and assembled in 8 days at Transasia's Vizag manufacturing facility Named iLAB, it was officially flagged off
5-day institutional quarantine made mandatory for COVID-19 patients in Delhi
Delhi Lieutenant Governor Anil Baijal has passed an order making five-day institutional quarantine mandatory for all those who test COVID-19 positive. The patients will
Glenmark gets nod for favipiravir to treat mild to moderate COVID-19 patients
Glenmark Pharmaceuticals has received manufacturing and marketing approval from India's drug regulator to launch the oral antiviral drug favipiravir for the treatment of mild